Skip to main content
SpringerLink
Log in

Influenza Virus Vaccine Live Intranasal — Aviron

Flumist™, Influenza Vaccine Live Intranasal

  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

References

  1. Nichol KL, Mendelman PM, Mallon KP, Live Attenuated Influenza Virus Vaccine in Healthy Adults Trial Group, et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. Journal of the American Medical Association 282: 137–144, 14 Jul 1999

    Article  PubMed  CAS  Google Scholar 

  2. Jackson LA, Holmes SJ, Mendelman PM, et al. Safety of a trivalent live attenuated intranasal influenza vaccine, FluMist (TM), administered in addition to parenteral trivalent inactivated influenza vaccine to seniors with chronic medical conditions. Vaccine 17: 1905–1909, 9 Apr 1999

    Article  PubMed  CAS  Google Scholar 

  3. Clements ML, Makhene MK, Karron RA, Murphy BR, Steinhoff MC, et al. Effective immunization with live attenuated influenza Avirus can be achieved in early infancy. Journal of Infectious Diseases 173: 44–51, Jan 1996

    Article  PubMed  CAS  Google Scholar 

  4. Gorse GJ, Otto EE, Powers DC, Chambers GW, Eickhoff CS, et al. Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly. Journal of Infectious Diseases 173: 285–290, Feb 1996

    Article  PubMed  CAS  Google Scholar 

  5. King Jr JC, Lagos R, Bernstein DI, Piedra PA, Kotloff K, et al. Safety and immunogenicity of low and high doses of trivalent live cold-adapted influenza vaccine administered intranasally as drops or spray to healthy children. Journal of Infectious Diseases. 177: 1394–1397, May 1998

    Article  PubMed  Google Scholar 

  6. Gruber W, Belshe R, Mendelman P, NIAID Vaccine and Treatment Evaluation Units and Aviron, et al. Immunologic response to heterotypic H3N2 strains after live intranasal or inactivated intramuscular influenza vaccine in children. Clinical Infectious Diseases 27: 933, Oct 1998

    Google Scholar 

  7. Boyce TG, Gruber WC, Coleman-Dockery SD, Sannella EC, Reed GW, et al. Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children. Vaccine 18: 82–88, 20 Aug 1999

    Article  PubMed  CAS  Google Scholar 

  8. Longini Jr IM, Halloran ME, Nizam A, Wolff M, Mendelman PM, et al. Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control. Vaccine 18: 1902–1909, 17 Mar 2000

    Article  PubMed  CAS  Google Scholar 

  9. Belshe RB, Gruber WC, Mendelman PM, Cho I, Reisinger K, et al. Efficacy of vaccination with live attenuated, coldadapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. Journal of Pediatrics 136: 168–175, Feb 2000

    Article  PubMed  CAS  Google Scholar 

  10. Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. New England Journal of Medicine 338: 1405–1412, 14 May 1998

    Article  PubMed  CAS  Google Scholar 

  11. Belshe RB, Gruber WC, Mendelman PM, Mehta HB, Mahmood K, et al. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. Journal of Infectious Diseases 181: 1133–1137, Mar 2000

    Article  PubMed  CAS  Google Scholar 

  12. Zangwill KM, Droge J, Mendelman P, Marcy SM, Partridge S, et al. Prospective, randomized, placebo-controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young children. Pediatric Infectious Disease Journal 20: 740–746, Aug 2001

    Article  PubMed  CAS  Google Scholar 

  13. Treanor JJ, Kotloff K, Betts RF, Belshe R, Newman F, et al. Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenzaA(H1N1), A(H3N2), and B viruses. Vaccine 18: 899–906, 10 Dec 1999

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Influenza Virus Vaccine Live Intranasal — Aviron. Drugs R&D 3, 123–129 (2002). https://doi.org/10.2165/00126839-200203020-00014

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-200203020-00014

Keywords

Search

Navigation